US 12,258,308 B2
Benzene derivative
Shoji Nojima, Osaka (JP); Kenji Sasaki, Osaka (JP); Tohru Kambe, Osaka (JP); Takashi Konemura, Osaka (JP); and Yoshikazu Goto, Osaka (JP)
Assigned to Ono Pharmaceutical Co., Ltd., Osaka (JP)
Filed by ONO PHARMACEUTICAL CO., LTD., Osaka (JP)
Filed on Dec. 7, 2021, as Appl. No. 17/544,616.
Application 17/544,616 is a continuation of application No. 17/264,603, granted, now 11,261,154, previously published as PCT/JP2019/029883, filed on Jul. 30, 2019.
Claims priority of application No. 2018-143024 (JP), filed on Jul. 31, 2018.
Prior Publication US 2022/0089532 A1, Mar. 24, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. C07C 311/21 (2006.01)
CPC C07C 311/21 (2013.01) 12 Claims
 
1. A method of promoting differentiation of a Schwann cell, comprising contacting a cell with 3-[2-[(E)-5-[3-(benzenesulfonamido)phenyl]pent-4-enoxy]phenyl]propanoic acid or a salt thereof.